Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 5/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13621021 | 0.86 | NPC1 (0.50) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13621006 | 0.85 | NPC1 (0.51) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL4359314 | 0.85 | NPC1 (0.54) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13134564 | 0.84 | ATR (0.44) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13621000 | 0.83 | NPC1 (0.56) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13620995 | 0.82 | ALDH1A1 (0.50) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13621020 | 0.82 | NPC1 (0.48) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27365149 | 0.82 | NPC1 (0.67) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13620986 | 0.80 | NPC1 (0.51) | NPC1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13621001 | 0.80 | ALDH1A1 (0.50) | NPC1ALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859108-B2 | Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8859108-B2 | Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABARATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABARATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | CYP4X1, XDH, GABRA5 | NPC1 3482/4885ALDH1A1 169/4885KDM4E 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.